title: Characterization and application of two novel monoclonal antibodies against human OX40: costimulation of T cells and expression on tumor as well as normal gland tissues.
abstract: OX40, a membrane-bound molecule of the tumor-necrosis-factor-receptor superfamily, is a critical costimulatory receptor during the immune response. Here, we newly generated two specific mouse antihuman OX40 monoclonal antibodies (mAbs) (2G2 and 1F7), whose specificities are quite different from the available OX40 mAb (ACT35) by competition assay. It was also found that both mAbs could enhance the proliferation, activation and differentiation of T lymphocytes primed by anti-CD3 mAb. These results evidenced that both were functional antihuman OX40 mAbs. Furthermore, stained by 2G2 and 1F7, FCM and immunohistochemistry detected the constitutive expression of OX40 on tumor cell lines from epithelium, breast cancer and glioma tissues. Meanwhile, the non-tumor tissues (thyroid gland, stomach gland) were also found OX40 expression. These results suggested that OX40 is not only expressed in activated T cells, but also in some tumors as well as normal gland tissues. Such expression pattern indicated that OX40 may be a valuable surface antigen in unveiling its expression and function outside the immune system. Briefly, these novel antibodies may contribute to the evaluation of the mechanism of tumor metastasis and eventually shed light on further study of tumor immunotherapy and autoimmune diseases.
authors.affiliation: Institute of Biotechnology and Clinical Immunology Research Laboratory of Jiangsu Province, Soochow University, 48#, Renmin Road, Suzhou, 215007, PR China.
authors.forename: F
authors.initials: F
authors.lastname: Xie
authors.forename: Q
authors.initials: Q
authors.lastname: Wang
authors.forename: Y
authors.initials: Y
authors.lastname: Chen
authors.forename: Y
authors.initials: Y
authors.lastname: Gu
authors.forename: Q
authors.initials: Q
authors.lastname: Shi
authors.forename: Y
authors.initials: Y
authors.lastname: Ge
authors.forename: G
authors.initials: G
authors.lastname: Yu
authors.forename: H
authors.initials: H
authors.lastname: Wu
authors.forename: Y
authors.initials: Y
authors.lastname: Mao
authors.forename: X
authors.initials: X
authors.lastname: Wang
authors.forename: Y
authors.initials: Y
authors.lastname: Zhou
authors.forename: X
authors.initials: X
authors.lastname: Zhang
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D015153:Blotting, Western; D001943:Breast Neoplasms / Q000276:immunology* / Q000473:pathology; D002454:Cell Differentiation / Q000276:immunology; D004848:Epithelium / Q000276:immunology; D005434:Flow Cytometry; D005910:Glioma / Q000276:immunology* / Q000473:pathology; D006801:Humans; D008213:Lymphocyte Activation; D051379:Mice; D008807:Mice, Inbred BALB C; D053262:Receptors, OX40; D018124:Receptors, Tumor Necrosis Factor / Q000276:immunology*; D013270:Stomach / Q000166:cytology; D013601:T-Lymphocytes / Q000276:immunology*; D013961:Thyroid Gland / Q000166:cytology
chemical_list: D000911:Antibodies, Monoclonal; D053262:Receptors, OX40; D018124:Receptors, Tumor Necrosis Factor; C505716:TNFRSF4 protein, human; C505717:Tnfrsf4 protein, mouse